TissueCypher® Outperforms Pathologist Diagnoses When Pr

Press release content from Business Wire. The AP news staff was not involved in its creation.

Related Keywords

University Medical Center , Texas , United States , Friendswood , Netherlands , Amsterdam , Noord Holland , Castle Biosciences , Allison Marshall , Jacques Bergman , Camilla Zuckero , Decisiondx Diffdx , Laboratory Test , Instagram , Centers For Medicare Medicaid Services , Linkedin , Castle Biosciences Inc , Twitter , Nasdaq , Securities Exchange , Facebook , Tissuecypher Barrett , Digestive Disease Week , Fully Automated Barrett , Risk Prediction Assay Outperforms Pathology , Risk Stratifying Barrett , Low Grade Dysplasia , Medical Center , Advanced Diagnostic Laboratory Test , Medicaid Services , Path Melanoma , Decisiondx Diffdx Melanoma , Securities Act , Securities Exchange Act , Quarterly Report , Investor Contact , Business Wire , Covid 19 , Health , Cancer ,